Rephonic
Artwork for Research To Practice

Research To Practice | Oncology Videos

Dr Neil Love
Immunotherapy
Prostate Cancer
Chronic Lymphocytic Leukemia
Ovarian Cancer
PARP Inhibitors
Endometrial Cancer
Multiple Myeloma
Colorectal Cancer
Pembrolizumab
Small Cell Lung Cancer
Antibody-Drug Conjugates
HER2
Bispecific Antibodies
Follicular Lymphoma
Gastroesophageal Cancer
Diffuse Large B-Cell Lymphoma
Cdk4-6 Inhibitors
Breast Cancer
Non-Small Cell Lung Cancer
Belantamab Mafodotin

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

PublishesDailyEpisodes1524Founded13 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Research To Practice

Latest Episodes

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics:

• Case: A woman in her late 60s with a germline BRCA2 mutation and h... more

Featuring an interview with Prof Karim Fizazi, including the following topics:

• Perspectives on the PROTEUS Phase III trial evaluating the addition of apalutamide to standard therapy for high-risk localized prostate cancer (0:00)

• Mechanism of ... more

Featuring a slide presentation and related discussion from Prof Karim Fizazi, including the following topics:

• PROTEUS Phase III trial evaluating the addition of apalutamide to standard therapy in high-risk localized prostate cancer (0:00)

• T... more

Featuring perspectives from Prof Susana Banerjee, including the following topics:

• Case: A woman in her mid 50s with multiregimen-recurrent low-grade serous ovarian cancer and a KRAS G12V mutation who receives avutometinib/defactinib with respons... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Jonathan Letterman
Professor, UCL Cancer Institute (pre-recorded video presentations)
UCL Cancer Institute
Episode: Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Ursula Matulonis
Dr. Ursula Matulonis, Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Angela Secord
Dr. Angela Secord, Duke Cancer Institute
Duke University
Episode: Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Jonathan Ledermann
Professor at UCL Cancer Institute, London
UCL Cancer Institute
Episode: Ovarian Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Ursula Matalonis
Dr. from Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Ovarian Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Noopur Raje
Director of the Center for Multiple Myeloma and Plasma Cell Disorders at Massachusetts General Brigham Cancer Institute
Massachusetts General Brigham Cancer Institute
Episode: Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting
Meletios-Athanasios (Thanos) C Dimopoulos
Professor and chair of the Plasma Cell Unit at the National and Kapodistrian University of Athens
National and Kapodistrian University of Athens
Episode: Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting
Sara Tolaney
Medical oncologist at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney
Matthew S. Davids
CLL investigator at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Hosts

Neil Love
Host from Research To Practice; frequently guides discussions and presents consensus updates; associated with multiple program strands including Year in Review and CME-linked content.
Seth Wander
Moderator from Boston introducing and guiding the session.
Misty Shields
Host of Second Opinion CME meeting; coordinates session flow.
Yelena Janjigian
Moderator of the discussion; prominent oncology expert.
John Heymach
Oncologist presenting expert insights; thoracic oncology focus.

Reviews

4.6 out of 5 stars from 156 ratings
  • Still the best and still addicted!

    I am a retired pharmacist and my husband still listens with me. Dr. Love is the best at getting to what is important for day to day treatment. Soooo good I can’t give it up. Thank you all for continuing be an inspiration to this old woman. In my next life……….❤️

    Apple Podcasts
    5
    Redbat7
    United States2 months ago
  • Valued resource

    Relentless in its focus on the general medical oncolgist. An important resource.

    Apple Podcasts
    5
    a h/o
    United States5 years ago
  • Excellent

    Since my fellowship training Neil Love has made these presentations the best of the best in staying UpToDate with current and future practice

    Apple Podcasts
    5
    obete man
    United States5 years ago
  • RTP is is consistently great

    Research to Practice continues to put out well produced clinically relevant content from expert faculty that is applicable to daily oncology practice. It is an invaluable resource for me.

    Apple Podcasts
    5
    OKMedStudent
    United States6 years ago
  • Gold standard

    I’m not an oncologist but I love listening to all of these podcasts. I have to imagine that Neil Love is an absolute giant in this field. So interesting and informative.

    Apple Podcasts
    5
    Bob a la sob mob
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

- Appreciated even by non-oncologists for its informative discussions.
- Valuable resource for staying current with general medical oncologists.
- Consistently high-quality, clinically relevant content from expert faculty.
- A well-produced source of practical oncology knowledge for daily practice.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#227
Australia/Science
Apple Podcasts
#77
China/Science
Apple Podcasts
#187
Brazil/Science
Apple Podcasts
#248
Ireland/Science

Talking Points

Recent interactions between the hosts and their guests.

Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management
Q: What would you usually present to a patient with TP53 wild-type, unmutated IGHV CLL who wants time-limited therapy and has difficulty getting to clinic?
Catherine C. Coombs would favor acalabrutinib plus venetoclax or venetoclax plus obinutuzumab, rather than the triplet for an older patient. She favors the all-oral acalabrutinib combination for convenience and bulky lymphadenopathy.
Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management
Q: If MRD is so prognostic, why does it not go away with continuous BTK inhibitors even though patients can have long progression-free survival?
Matthew S. Davids explains that continuous BTK inhibitor treatment aims to control CLL, so residual disease may remain while patients stay on therapy. MRD is more predictive when evaluating whether time-limited treatment has produced a deep response.
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting
Q: What kinds of patients would you consider to be good candidates, and how early would you administer it?
Dimopoulos says belantamab combinations can suit older patients and those who prefer fewer visits to a chemotherapy unit, and supports starting treatment at biochemical relapse.
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting
Q: For which patients are you thinking about using TEC-DARA? Or do you still in some cases like to do bispecific antibody monotherapy? And tell us a little bit about what you're thinking in terms of sequencing.
Raje considers teclistamab plus daratumumab appropriate for patients previously exposed to daratumumab who have been off it for a while, and favors bispecific monotherapy for very old or frail patients.
Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 3 with Dr Sara M Tolaney
Q: Do you consider these equivalent from the point of view of efficacy, or might datopotamab deruxtecan be more efficacious?
Tolaney considers the drugs likely similar in efficacy based on their progression-free survival hazard ratios. She says toxicity differences, including mucositis and ocular effects with datopotamab deruxtecan versus neutropenia and diarrhea with sacituzumab govitecan, can help guide choices.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Research To Practice

What is Research To Practice about and what kind of topics does it cover?

This program concentrates on cutting-edge oncology practice, featuring expert clinicians and researchers discussing recent data, pivotal trials, and real-world management strategies across solid tumors and hematologic cancers. Episodes frequently cover new therapies, biomarker-guided treatment, sequencing decisions, and practical toxicity management, often tied to major conferences and pivotal symposiums. A standout element is the breadth of high-profile guest experts and the emphasis on translating trial data into clinical decision-making, including transplant eligibility, maintenance strategies, and emerging targeted therapies. Overall, it's a resource for practitioners seeking up-to-date, clinically actionable insights and nuanced expert... more

Where can I find podcast stats for Research To Practice?

Rephonic provides a wide range of podcast stats for Research To Practice. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Research To Practice and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Research To Practice get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Research To Practice, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Research To Practice?

Rephonic provides comprehensive predictive audience data for Research To Practice, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Research To Practice have?

To see how many followers or subscribers Research To Practice has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Research To Practice?

These podcasts share a similar audience with Research To Practice:

1. Two Onc Docs
2. Oncology Today with Dr Neil Love
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. JAMA Clinical Reviews
5. OncLive® On Air

How many episodes of Research To Practice are there?

Research To Practice launched 13 years ago and published 1524 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Research To Practice?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Research To Practice?

Rephonic pulls ratings and reviews for Research To Practice from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Research To Practice?

Rephonic provides full transcripts for episodes of Research To Practice. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Research To Practice?

Recent guests on Research To Practice include:

1. Jonathan Letterman
2. Ursula Matulonis
3. Angela Secord
4. Jonathan Ledermann
5. Ursula Matalonis
6. Noopur Raje
7. Meletios-Athanasios (Thanos) C Dimopoulos
8. Sara Tolaney

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days